These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33558294)

  • 1. High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study.
    Auriti C; Goffredo BM; Ronchetti MP; Piersigilli F; Cairoli S; Bersani I; Dotta A; Bagolan P; Pai MP
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study.
    Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR
    BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age.
    Abdel-Haq N; Smith SM; Asmar BI
    Expert Rev Anti Infect Ther; 2022 Apr; 20(4):493-505. PubMed ID: 34882043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of micafungin in infants: insights into optimal dosing.
    Ascher S; Smith PB; Benjamin DK
    Expert Opin Drug Saf; 2011 Mar; 10(2):281-6. PubMed ID: 21226655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
    BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
    Tsekoura M; Ioannidou M; Pana ZD; Haidich AB; Antachopoulos C; Iosifidis E; Kolios G; Roilides E
    Pediatr Infect Dis J; 2019 Jan; 38(1):42-49. PubMed ID: 29596219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of invasive neonatal candidiasis.
    Botero-Calderon L; Benjamin DK; Cohen-Wolkowiez M
    Expert Opin Pharmacother; 2015 May; 16(7):1035-48. PubMed ID: 25842986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!
    Gumbo T
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S635-42. PubMed ID: 26567282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.
    Autmizguine J; Hornik CP; Benjamin DK; Brouwer KL; Hupp SR; Cohen-Wolkowiez M; Watt KM
    Pediatr Infect Dis J; 2016 Nov; 35(11):1204-1210. PubMed ID: 27314826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer.
    Farmakiotis D; Tarrand JJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3526-9. PubMed ID: 24637687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old.
    Bassetti M; Giacobbe DR; Vena A; Esposito S
    Expert Opin Pharmacother; 2022 Dec; 23(18):1987-1993. PubMed ID: 36373395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
    Montejo M; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
    Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
    Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.
    Knitsch W; Vincent JL; Utzolino S; François B; Dinya T; Dimopoulos G; Özgüneş İ; Valía JC; Eggimann P; León C; Montravers P; Phillips S; Tweddle L; Karas A; Brown M; Cornely OA
    Clin Infect Dis; 2015 Dec; 61(11):1671-8. PubMed ID: 26270686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis.
    Benjamin DK; Deville JG; Azie N; Kovanda L; Roy M; Wu C; Arrieta A
    Pediatr Infect Dis J; 2013 Nov; 32(11):e419-25. PubMed ID: 23958810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
    Benjamin DK; Kaufman DA; Hope WW; Smith PB; Arrieta A; Manzoni P; Kovanda LL; Lademacher C; Isaacson B; Jednachowski D; Wu C; Kaibara A; Walsh TJ
    Pediatr Infect Dis J; 2018 Oct; 37(10):992-998. PubMed ID: 29596222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.